Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

(d) On January 10, 2013, the Corporate Governance Committee of the Board of Directors of SciClone Pharmaceuticals, Inc. (the "Company"), acting on the authority of the Board of Directors of the Company (the "Board"), appointed Simon Li to serve as a member of the Board, effective immediately. Mr. Li's term will expire at the 2013 annual meeting of stockholders, and he will be subject to the election of the Company's stockholders at that meeting. In connection with his appointment, Mr. Li has not yet been appointed to serve as a member of any committee of the Board.

A copy of the Company's press release announcing Mr. Li's appointment is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

(d) The following exhibits are filed herewith:

Exhibit 99.1 Press release dated January 14, 2013.

---